Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. - Test2 - elhamkhani - TriplyDB

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

http://www.wikidata.org/entity/Q34327732

about

Limbic Encephalitis: Potential Impact of Adaptive Autoimmune Inflammation on Neuronal Circuits of the Amygdala Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions Neuronal central nervous system syndromes probably mediated by autoantibodies Seizures and Epilepsies due to Channelopathies and Neurotransmitter Receptor Dysfunction: A Parallel between Genetic and Immune Aspects Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies Acquired neuromyotonia heralding recurrent thymoma in myasthenia gravis.Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures.[(18)F]-Fluoro-Deoxy-Glucose Positron Emission Tomography Scan Should Be Obtained Early in Cases of Autoimmune Encephalitis Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies Hemichorea Associated with CASPR2 Antibody.Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre.The neurologic significance of celiac disease biomarkers Copy number variations in a population-based study of Charcot-Marie-Tooth disease A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report Clinical relevance of voltage-gated potassium channel–complex antibodies in children.Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex.A clinical approach to diagnosis of autoimmune encephalitis.When dementia progresses quickly: a practical approach to the diagnosis and management of rapidly progressive dementia.Isaacs syndrome: A review.Autoimmune Encephalitis in the ICU: Analysis of Phenotypes, Serologic Findings, and Outcomes.Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies.Clinical utility of seropositive voltage-gated potassium channel-complex antibody.Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis.Innate and adaptive immunity in human epilepsies.Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.Sensorimotor polyneuropathy and foot-drop as result of a prostate cancer paraneoplastic syndrome.P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments.The clinical spectrum of Caspr2 antibody-associated disease.Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.Eyelid tremor in a patient with anti-caspr2 antibody-related encephalitis.Neurological manifestations related to level of voltage-gated potassium channel antibodies.MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis.Cramp-fasciculation syndrome in patients with and without neural autoantibodies.The clinical relevance of voltage gated potassium channel (VGKC)-complex antibodies: the story is still unfolding.LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.

P2860

Q26797363-BCD32FB5-6F57-446D-AEEA-E64A60F19E37 Q26824216-F272E20C-215D-4CB5-BEF5-AE88B78E212D Q28072253-3F42B0FF-C228-4E9B-AB21-73D0843E9DBA Q28079865-7A948A9A-D053-4D58-82B1-1CD23C92B8E9 Q28084055-0731974A-6583-4498-8D47-4434D7E51A51 Q30583597-07220046-CBBE-492D-A925-3B4792BB2934 Q30666620-104BE6AA-79E4-4163-96F2-EA5AF53B30D0 Q31123502-4B182806-6C92-420A-B3E5-BE8531467B1E Q33600142-EADAF2D6-4244-4DC5-BE85-B58758A5F8AB Q33688735-1DD47F2A-3CA3-4715-B9EE-DF5CAFC73514 Q34088519-2342F311-789F-4CF2-BFEB-DF117DA2DDDF Q34350247-FE72BAC1-C0BC-4090-A821-A28E58510F93 Q34449781-96C7D648-447A-4118-B5F9-7876A69B4074 Q34556510-B28C055D-A794-4045-9E42-45B6ED549207 Q35013000-8132EF09-3EB1-408F-A6D1-76DE06EF10DE Q35960033-688E3F41-96B4-45EE-8E11-304B47AAACF0 Q36052949-4BEC6605-AF91-4E68-B465-649C7A5A4C9D Q36760291-A851E06C-A73A-4DAD-9B07-6B786984328A Q37343730-A3451509-B042-4740-8FE0-E76C8C7F6028 Q38196861-0ACCCF4F-7235-49BA-99A6-4FB70543FF6B Q38367371-AE1130E1-6A18-4C64-B15B-2C4197900DC4 Q38576199-412C99DF-F029-4137-A9C1-B8BF7AF8EC1C Q38902329-73AE2BB5-04FB-49EA-B4A9-8BF62D30DA91 Q39009676-B5DDDA18-AED5-440E-8FBC-07393EC463B1 Q39945806-1CD72F5A-9F42-48B5-8A8E-343849831685 Q40135696-48007BC2-84E3-4258-AD50-E35BFCC4E9C0 Q40154528-8869E6DF-B375-4340-882A-55904228ADBD Q42155183-6E4A62BF-EB6A-4AD8-8267-EF13D270EC33 Q42161070-F724DE3D-9E79-4B9E-B713-B4D9F25E743A Q42385999-4658687F-726F-4226-B134-12C8B725CC77 Q42687320-659313DA-0FE1-41FD-835A-10FC8589E424 Q42917447-E91AA2CF-4728-4DE0-A957-9B388F4002B5 Q43596658-250867DC-72FC-4F53-969F-9FB677F7D47C Q43861744-EDE1E147-FA9D-4F2B-A539-C3A5BB05F744 Q44300420-67C44FFE-1C41-4547-A6FA-7631DCF11C36 Q44725469-B994351F-6851-45F1-93D2-98DF0201FDD7 Q46278362-85E1C39A-AFF8-4A50-96D4-DE3CCB481119 Q47188113-BBC45ACF-A379-4580-B59F-A8C82DAA0686 Q47623969-2DDCBE7C-BA95-4292-890F-EA8A9D1EB500 Q47942669-5C0490B1-C91F-4C9A-ABF3-FB9AE48B7076

P2860

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

http://www.wikidata.org/entity/Q34327732

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

@ast

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

@en

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

@nl

type

label

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

@ast

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

@en

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

@nl

prefLabel

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

@ast

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

@en

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

@nl

P1433

Q34327732-9E59C353-52EC-4922-9057-8D22C03694DC

P1476

Q34327732-B7672CC3-C94F-47BB-A3DA-DF8FCBC928D1

P2093

Q34327732-015E5AD9-956F-471A-BBFF-5F9E55317BBB

Q34327732-6C9853CD-17B3-46B1-9067-D617C58E5203

Q34327732-CCD101E3-C161-4A40-9BDB-CA87E146608A

Q34327732-D82B9658-9EF7-4387-A394-0DF95E1F2104

Q34327732-FE550D45-6E85-4331-9D64-F518F366026F

P2860

Q34327732-00A61784-43EB-467A-80A7-6E6320DCF445

Q34327732-08489389-E7D2-4EDF-9DD4-C114DDD9DE17

Q34327732-31E63DD8-D15E-4535-8934-B4BD25F16843

Q34327732-493F0D00-BEA5-46F0-A79D-18B37A4170A7

Q34327732-5ED0B14B-96E3-4AF8-9210-420052367DC7

Q34327732-637D2EC0-BEED-4AF4-9F22-6AE9DF755829

Q34327732-6DB92AEB-7322-47BB-8D76-AA0A033106E4

Q34327732-72499047-3587-4910-AF17-8D0E9CA7E2C8

Q34327732-79EE4B12-83AB-4849-8BAD-C2EF90207F7F

Q34327732-7BD5DAAA-8D26-47E8-A656-A45653030D27

P304

Q34327732-B6E3CB60-9B6B-4627-BBEC-155565F5E01F

P31

Q34327732-F052A3F5-2A3E-4356-BAF2-2E59A960B63E

P356

Q34327732-38CA5940-E0C6-4977-B3C9-D3E73B31ABA5

P407

Q34327732-A5EEBB7D-3BF5-426F-B5D8-BFCEE5C3760B

P433

Q34327732-F8C97241-AB9E-4060-847D-7FB05866B8D4

P478

Q34327732-DE584DA3-903F-44D8-BD92-4BA6FE4E1BA4

P50

Q34327732-1E72368A-F673-477F-B602-807D7F6897A0

Q34327732-8E1A876D-2817-42F3-90B6-897C6A4583E3

P577

Q34327732-35931EFA-2EBE-4927-8BD2-75732CB1D394

P5875

Q34327732-4DFC6825-FDBD-441B-8723-0B8F3F9EFC5C

P698

Q34327732-7A03CB8A-D462-42E8-B277-5406063A5866

P921

Q34327732-5A35E1D8-24E8-413A-8BC8-10625530E07E

P932

Q34327732-307D98FA-B381-4B0B-AAFD-617750452911

P356

JAMANEUROL.2013.592

P1433

P1476

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping

@en

P2093

Amy Quek

http://www.w3.org/2001/XMLSchema#string

Orna O'Toole

http://www.w3.org/2001/XMLSchema#string

Paula A Aston

http://www.w3.org/2001/XMLSchema#string

Sean J Pittock

http://www.w3.org/2001/XMLSchema#string

Vanda A Lennon

http://www.w3.org/2001/XMLSchema#string

P2860

Autoimmune dementia: clinical course and predictors of immunotherapy response

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels.

Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series

Autoimmune epilepsy: clinical characteristics and response to immunotherapy

Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves.

Neurophysiologic studies in Morvan syndrome.

Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia.

Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia

P304

229-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMANEUROL.2013.592

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Christopher J. Klein

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235620823

http://www.w3.org/2001/XMLSchema#string

P698

23407760

http://www.w3.org/2001/XMLSchema#string

P921

P932

3895328

http://www.w3.org/2001/XMLSchema#string